Related Experiment Video
Updated: Dec 12, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
A Survey on National Pediatric Antibiotic Stewardship Programs, Networks and Guidelines in 23 European Countries
Ioannis Kopsidas1, Stefania Vergnano2, Nikos Spyridis3
1From the Penta Foundation, Padua, Italy.
Insights
Pediatric antibiotic stewardship (PAS) programs in Europe show fragmented implementation, with few national guidelines, competencies, or agreed metrics for antibiotic prescribing in children, contributing to antimicrobial resistance.
Area of Science:
- Infectious Diseases
- Public Health
- Pharmacology
Background:
- Antimicrobial resistance (AMR) is a significant public health concern across Europe, exacerbated by antimicrobial misuse and overuse.
- Pediatric antibiotic stewardship (PAS) is crucial for combating AMR in children.
Purpose of the Study:
- To assess the current landscape of pediatric antibiotic stewardship (PAS) programs in Europe.
- To identify existing gaps in national PAS programs, networks, and guidelines.
Main Methods:
- A 17-question survey was distributed in July 2019 to European pediatric infectious disease experts.
- The survey focused on the presence of national PAS programs, networks, guidelines, competencies, and metrics.
Main Results:
- Responses were received from 23 countries, revealing varied implementation of national guidelines (70%), with many outdated.
- Few countries have established national PAS competencies (4/23) or networks (UK, Germany).
- A significant gap exists in agreed metrics for pediatric antibiotic prescribing (91% of countries lack them).
Conclusions:
- The fragmented implementation of PAS programs, lack of standardized metrics, and absence of national networks and competencies are concerning.
- These gaps hinder effective antimicrobial stewardship in pediatric populations, potentially worsening antimicrobial resistance across Europe.
Background:
Misuse, overuse of antimicrobials and increasing rates of antimicrobial resistance are well-recognized problems throughout Europe. The aim of this survey was to describe the current pediatric antibiotic stewardship (PAS) landscape across Europe and identify gaps, in terms of national programs, networks and guidelines.
Methods:
A survey of 17 questions was circulated in July 2019 among 24 European pediatric infectious disease researchers and clinicians, professors and heads of department on the existence of PAS programs, national networks and meetings, established competencies, metrics and guidelines.
Results:
We received responses from 23 countries. National guidelines on the management of children with common infections treated in hospital settings exist in 15 of 23 (70%); only 8 of 15 (53%) had been updated within the previous 4 years. Most provide guidance on antibiotic initiation and duration (14 of 15, 93%), but few on when to transition from intravenous to oral antibiotics (7 of 15, 47%). National PAS competencies have only been developed in 4 countries; only 1 addressed both community and hospital prescribing. Organized national PAS networks are only established in the United Kingdom and Germany; 21 of 23, 91% countries had no agreed metric for antibiotic prescribing in children; 2 of 23 were based on daily defined doses.
Conclusions:
Fragmented implementation of PAS programs, no agreed metrics, lack of established PAS competencies and national PAS networks along with inexistent funding is alarming in view of existing high rates of antimicrobial resistance in Europe.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antibiotic Selection

